ライフサイエンスコーパス: mortality rate

1 ty (standardised mortality ratios [SMRs] and mortality rates).

2 ecutive organ failures and a high short-term mortality rate.

3 e common vascular diseases that carry a high mortality rate.

4 ICU in Australia and New Zealand have a high mortality rate.

5 fants is associated with major reductions in mortality rate.

6 monstrated significant organ failure and 14% mortality rate.

7 c cancer is a malignant neoplasm with a high mortality rate.

8 can Americans have the highest breast cancer mortality rate.

9 e human population with an approximately 35% mortality rate.

10 lized cecal contents also resulted in a high mortality rate.

11 No individual trial showed a decreased mortality rate.

12 docarditis, leading to a strong reduction of mortality rate.

13 ated with drug-resistant seizures and a high mortality rate.

14 urve, scaled Brier's score, and standardized mortality rate.

15 ive treatment, IPF is associated with a high mortality rate.

16 est influenza-associated hospitalization and mortality rates.

17 een county ischemic heart disease and stroke mortality rates.

18 Annual infant mortality rates.

19 Health Estimate (GHE) respiratory infection mortality rates.

20 KI) remains a major clinical event with high mortality rates.

21 al anesthesia, and it has high morbidity and mortality rates.

22 with liver cirrhosis is associated with high mortality rates.

23 ve Google search volume also correlated with mortality rates.

24 to assess variables associated with 12-week mortality rates.

25 n in asymptomatic individuals coincides with mortality rates.

26 ificant factor in evaluating hospital 30-day mortality rates.

27 ere outbreaks of hemorrhagic fever with high mortality rates.

28 continue to cause unacceptable morbidity and mortality rates.

29 strongly on assumptions about parasite-based mortality rates.

30 ng the highest extinction risk under current mortality rates.

31 weaker social ties had significantly higher mortality rates.

32 een used, but case studies show no impact on mortality rates.

33 risk, resulting in falsely high standardized mortality rates.

34 y, persistent cognitive problems, and higher mortality rates.

35 specific (heart disease, cancer, and stroke) mortality rates.

36 han catheters because of significantly lower mortality rates.

37 small villages in an Indian state with high mortality rates.

38 disease (WTD) are associated with up to 100% mortality rates.

39 nal death indicators, including the maternal mortality rate (1.7 per 1000 women of reproductive age,

40 eatic fistula (21.1% vs 14.6%; P < 0.01) and mortality rates (1.5% vs 0.3%; P = 0.04).

41 at baseline, 3,389 deaths occurred (overall mortality rate 16.5 per 1,000), along with 9,746 cases o

42 Risk-adjusted hospital-level mortality rates, 30-day readmission rates, length of sta

43 attributable to cancer (cancer-attributable mortality rate 327 per 100000 person-years).

44 re less likely to suffer melanoma-associated mortality (rate = 4.68/1,000 person-years) compared with

45 evidence of AKI and had the lowest hospital mortality rate (5%).

46 arly initiation group had a 1-year all-cause mortality rate (56 of 111 [50.2%]) significantly lower t

47 rative morbidity (37% vs 40%, P = 0.489) and mortality rates (6% vs 4%, P = 0.214) were comparable be

48 ained associated with an increased all-cause mortality rate (9 studies, 3649 patients; RR, 1.97; 95%

49 1.1-2.1), and a 2.2-fold increased all-cause mortality rate (95% CI = 1.9-2.5).

50 Naegleria fowleri is extremely lethal, with mortality rates above 95%.

51 found substantial heterogeneity in absolute mortality rates according to baseline risk groups.

52 In-hospital sepsis mortality rates adjusted for patient and hospital factor

53 Mortality rates adjusted for patient characteristics wer

54 The annualized mortality rate after a bleeding event was 21.5 (95% CI,

55 CHC was associated with a 2.4-fold higher mortality rate after adjustment for sociodemographic fac

56 The annualized mortality rate after an ischemic event was 27.2 (95% CI,

57 The mortality rate after infection with these viruses is hig

58 y decline was observed in either ACVD or CAD mortality rates after 2002.

59 orrelated with reductions in hospital 30-day mortality rates after discharge.

60 We compared postoperative mortality rates after inpatient surgery in South Carolin

61 Mortality rates after myocardial infarction (MI) are sig

62 8% [16 of 424 patients], P < .001), although mortality rates also decreased among the robust patients

63 There were large differences in the mortality rate among counties throughout the period: in

64 results demonstrate a nearly twofold higher mortality rate among individuals with treatment-resistan

65 The mortality rate among older PHIVY was 6 to 12 times that

66 no significant differences in overall 30-day mortality rates among patients treated by locum tenens c

67 Brazilian Amazon that observed increases in mortality rates among some tree species but not others,

68 rely halted vaccine trial revealed increased mortality rates among vaccine recipients in whom postsur

69 s, though no significant association between mortality rate and bypass was identified.

70 thal species of all ebolaviruses in terms of mortality rate and number of deaths.

71 ear inverse association between the baseline mortality rate and reduction in the risk of mortality.

72 The postoperative mortality rate and the retransplantation rate were simil

73 Plant mortality rates and biomass declines in response to drou

74 Significant differences in CVD mortality rates and changes over time were found among t

75 and canine distemper virus (CDV) cause high mortality rates and death in many carnivores.

76 ated biting rates to be largest and mosquito mortality rates and extrinsic incubation periods to be s

77 Severe hyperoxia was associated with higher mortality rates and fewer ventilator-free days in compar

78 s with IgA nephropathy (IgAN) had the lowest mortality rates and patients with IgAN or vasculitis had

79 an urgent need to rigorously estimate actual mortality rates and quantify effects of bycatch on popul

80 onia is a major contributor to morbidity and mortality rates and requires adequate diagnosis for corr

81 are trends in the primary outcome of under-5 mortality rates and secondary outcomes reflecting popula

82 nti-inflammatory cytokines would have higher mortality rates and that these biomarkers could improve

83 we estimate for the first time both bycatch mortality rates and their population-level effects on th

84 n uncommon situation with high morbidity and mortality rates, and delayed small bowel perforation is

85 has one of the world's lowest fertility and mortality rates, and the elderly population is projected

86 of severe acute malnutrition often have high mortality rates, and the reasons are not well understood

87 to estimate life expectancy, cause-specific mortality rates, and years of life lost (YLL) rates from

88 that variations in Alaskan forest growth and mortality rates are contingent on species composition.

89 Prostate cancer mortality rates are highest among men of African ancestr

90 those with unintentional injury with 5-year mortality rates as high as 20% being reported for recurr

91 has the world's highest under-5 and neonatal mortality rates as well as the highest naturally occurri

92 nt trend analysis of annual age-standardized mortality rates (ASMRs) for SLE and non-SLE causes by se

93 nce-specific factors had little influence on mortality rates associated with CC30 infections.

94 ost prominent factors that underpin the high mortality rates associated with most breast cancers (BC)

95 us of conservation efforts aimed at reducing mortality rates associated with ship strikes and entangl

96 oing lead extraction had the highest overall mortality rate at 1.9% (95% CI, 1.34-2.61) and CVE rate

97 The primary outcome measure was all-cause mortality rate at 2 weeks after enrolment in patients fo

98 s >/=4 in 55.7% of patients, and the overall mortality rate at 30 days was 43.3% with no difference b

99 s not associated with increased morbidity or mortality rates at 30 days overall or within patient sub

100 Mortality rates attributable to ADCs and NADCs were high

101 form of cancer worldwide and carries a high mortality rate attributed to lack of effective treatment

102 team was associated with lower-than-expected mortality rates based on preimplementation trends.

103 -specific hazard ratios for the contrasts in mortality rates between obesity categories.

104 Purpose To compare total and cause-specific mortality rates between physicians likely to have perfor

105 oup analysis compared HF hospitalization and mortality rates between treatment and control groups in

106 2030, with incidence of HIV and AIDs-related mortality rates both at less than one event per 1000 adu

107 ngly associated with higher working-age male mortality rates both between 1992 and 1998 (age-standard

108 lennium Development Goal 4 to reduce under-5 mortality rate by two-thirds between 1990 and 2015.

109 tral and western Africa, must reduce under-5 mortality rates by at least 8.8% per year, between 2015

110 To estimate age-standardized mortality rates by county from chronic respiratory disea

111 Age-standardized cancer mortality rates by county, year, sex, and cancer type.

112 Age-standardized cardiovascular disease mortality rates by county, year, sex, and cause.

113 Age-standardized mortality rates by county, year, sex, and cause.

114 thyroid cancer incidence and incidence-based mortality rates by histologic type and SEER stage for ca

115 3 trends in risk-adjusted in-hospital sepsis mortality rates by race/ethnicity to inform efforts to r

116 To estimate age-standardized mortality rates by US county from 29 cancers.

117 nvironmental factors in regulating birth and mortality rates can lead to erroneous demographic analys

118 Overall injury and mortality rates caused by landmines or UXO decreased ove

119 Associations between the EQI and mortality rates (CDC WONDER) for counties in the contigu

120 ope, -0.029; -.051 to -.008), and so did the mortality rate (change in slope, -0.015; -.021 to -.008)

121 nosed diabetes mellitus had a higher 180-day mortality rate compared to patients without diabetes mel

122 fied has a substantially lower event-related mortality rate compared with T2MI2007 and T1MI.

123 ient oliguria (AKI-UO stage 1) had increased mortality rates compared with patients without oliguria

124 vely, but does not increase the 30 or 90-day mortality rates compared with sigmoid resection.

125 Blacks and Hispanics had similar mortality rates compared with whites (adjusted hazard ra

126 Mortality rates, costs (inpatient, outpatient, medicatio

127 The IPD-related mortality rate declined after 7-valent PCV introduction

128 of death in the United States, although the mortality rate declined from 507.4 deaths per 100000 per

129 Standardized 1-year mortality rates declined for middle-aged patients with h

130 The maternal mortality rate decreased significantly between 2002 and

131 for all racial/ethnic groups increased, and mortality rates decreased by 5-7% annually.

132 Thirty-day mortality rates did not significantly differ based on ho

133 Mortality rate didn't differ between the IBD and non-IBD

134 ne targets and did not fully rescue the high mortality rate due to congenital hypothyroidism in these

135 Mortality rates due to CVD decreased from a mean of 414.

136 l-time tool to estimate cancer incidence and mortality rates, especially for cancers not included in

137 Crude mortality rate fell from 10.2% before to 9.4% after CDSS

138 -specific trends in the incidence and 1-year mortality rates following a first-time diagnosis of hear

139 Primary outcome was 30-day mortality rate for all hospitalizations and for 15 commo

140 Estimated decreases in mortality rate for CVD from 2003 to 2012 ranged from 85

141 The perioperative mortality rate for isolated septal myectomy in most cent

142 There was no reduction in mortality rate for noninfectious diseases, but a 43% red

143 on rates for surgical conditions, as well as mortality rates for all measured conditions.

144 e recipients of red blood cell transfusions, mortality rates for an ever-pregnant female donor vs mal

145 At 6 months, mortality rates for both pMCS and IABP were 50% (hazard

146 ly in Nigeria, leading to high morbidity and mortality rates for children <5 years of age.

147 ng hospital status was associated with lower mortality rates for common conditions compared with nont

148 Puerto Ricans experienced higher mortality rates for ischemic and hypertensive heart dise

149 The highest mortality rates for lung and colorectal cancer by occupa

150 asures of quality, including readmission and mortality rates for other conditions, and patient report

151 Mortality rates for ovarian cancer have declined only sl

152 56 597 twin livebirths to compute trends in mortality rates for singletons and twins.

153 Standardised mortality rates for suicides (p < 0.001) and infant mort

154 score of 17 (interquartile range 13-21), the mortality rates for the low, intermediate, and high perf

155 Mortality Database to estimate county-level mortality rates from 1980 to 2014 for chronic respirator

156 s, we analyzed trends in NYC-specific and US mortality rates from 1990 to 2011 for all causes, any CV

157 on models were used to estimate county-level mortality rates from 29 cancers: lip and oral cavity; na

158 To estimate age-standardized mortality rates from cardiovascular diseases by county.

159 ast in the US Since 1978, a sharp decline in mortality rates from coronary heart disease and stroke h

160 tries by comparing GHE respiratory infection mortality rates from countries without EMR estimates wit

161 at the incidence of sepsis is increasing and mortality rates from sepsis are decreasing.

162 n resource-poor countries is associated with mortality rates >50%.

163 owntick in coronary heart disease and stroke mortality rates had definitely occurred, at least in the

164 Variation in post-operative mortality rates has been associated with differences in

165 Observations: Population-based breast cancer mortality rates have been higher for African American co

166 Heat-related mortality rates have decreased continuously over time, w

167 While stroke mortality rates have decreased substantially in the past

168 the industrialized world, with age-adjusted mortality rates having declined to about one third of th

169 ased on preimplementation trends) and actual mortality rates (hospital mean of 6.48 deaths per 1000 a

170 The neonatal mortality rate in Andhra Pradesh was 44 per 1,000 live b

171 Between 1996 and 2015, the under-5 mortality rate in China declined from 50.8 per 1000 live

172 athy and less kidney dysfunction and a lower mortality rate in cisplatin-induced AKI.

173 The high mortality rate in critically ill elderly patients has le

174 a devastating inflammatory condition with a mortality rate in excess of 20%.

175 Despite advances in care, the mortality rate in patients requiring kidney replacement

176 Q fever-related mortality rate in patients with and without vascular inf

177 We estimated that the under-5 mortality rate in PMI countries was reduced from 28.9 to

178 At 28 days after randomization, mortality rate in the liberal group (primary endpoint of

179 At 90 days after randomization, mortality rate in the liberal group was lower (59% vs 70

180 justing for hospital characteristics, sepsis mortality rates in 2013 were similar for white (92.0 per

181 re associated with significant morbidity and mortality rates in children.

182 degenerative diseases and predicts increased mortality rates in healthy individuals.

183 dae family, causing severe illness with high mortality rates in humans.

184 virus (PEDV) causes severe diarrhea and high mortality rates in newborn piglets, leading to massive l

185 icens) whose nestlings have experienced high mortality rates in recent times.

186 In-hospital mortality rates in renal transplant recipients with STEM

187 iation between introduction of PMI and child mortality rates in sub-Saharan Africa (SSA).

188 nolysis (IVF) was recently linked to reduced mortality rates in the CLEAR III study and IVF represent

189 </=100 mmol/L) was associated with increased mortality rates in the context of lower sodium (</=138 m

190 Cancer mortality rates in the United States continue to decline

191 This high mortality rate is, in part, due to the inability to init

192 xpansion are also associated with changes in mortality rates, may have influenced our findings, altho

193 s, but a 43% reduction in infectious disease mortality rate (MRR, 0.57; 95% CI, .35-.93).

194 with a nonsignificant reduction in neonatal mortality rate (MRR, 0.70; 95% confidence interval [CI],

195 injuries in adults and children by analyzing mortality rates, neurologic outcomes, and adverse effect

196 tisystemic febrile infectious disease with a mortality rate of >/=50% without adequate antibiotic tre

197 Treatment was well tolerated, with a 6-week mortality rate of 0%.

198 re 2,305 deaths during treatment for a crude mortality rate of 1,021 deaths per 10,000 person-years.

199 ) were classified as having sepsis and had a mortality rate of 12.1%, and 347 (4.0%) had septic shock

200 n, per year during 2009-2013 and showed high mortality rate of 14%.

201 djusted analysis, late career surgeons had a mortality rate of 2.62% versus 1.97% for early career su

202 GS had a mortality rate of 2.98% compared with 1.68% for SO and 2

203 r complication of acute pancreatitis, with a mortality rate of 20-43% in untreated patients.

204 12.1%, and 347 (4.0%) had septic shock and a mortality rate of 32.3%.

205 he virus has infected 1,791 patients, with a mortality rate of 35.6%.

206 dence interval, 0.64 to 0.68; P<0.001), with mortality rates of 15%, 25%, and 42% at 6, 12, and 24 mo

207 irus disease (EVD) is a serious illness with mortality rates of 20-90% in various outbreaks.

208 The difference was retained at 1 year with mortality rates of 22.5% (95% CI, 17.6-27.4) versus 9.3%

209 trial population (n = 137) showed short-term mortality rates of 28.0% (score 0 to 2), 42.9% (score 3

210 of statin therapy and mortality, with 1-year mortality rates of 4.0% (5103 of 126139) for those recei

211 The high mortality rates of cancer patients receiving standard tr

212 can Americans have the highest incidence and mortality rates of colorectal cancer (CRC) of any ethnic

213 changes have impacted the incidence and the mortality rates of heart failure.

214 We examined the global incidence and mortality rates of liver cancer, and evaluated the assoc

215 More importantly, the mortality rates of male and female liver-specific miR-12

216 become an important outcome measure, as the mortality rates of most surgical procedures have decreas

217 However, the very high mortality rates of patients with XDR not receiving bedaq

218 condary endpoints were overall morbidity and mortality, rate of reoperation, length of hospital stay,

219 neuroinvasive disease accompanied by a high mortality rate or long-lasting neurologic sequelae.

220 ion-based or targeted screening can decrease mortality rates or improve important patient health outc

221 d to skilled-care facilities had the highest mortality rates (p-for-interaction: 0.08, 0.03, and 0.17

222 The mortality rates paralleled the incidence rates in most c

223 We calculated age-standardised all-cause mortality rates (per 100 000 person-years), stratified b

224 ith schizophrenia have a 2- to 3-fold higher mortality rate primarily caused by cardiovascular diseas

225 Thirty-day RARRs and 30-day risk-adjusted mortality rates (RAMRs) after discharge were calculated

226 ache and dizziness to coma and death, with a mortality rate ranging from 1 to 3%.

227 ek was associated with a substantially lower mortality rate ratio (mortality rate ratio = 0.64, 95% c

228 mortality risk, we determined the all-cause mortality rate ratio (MRR) for individuals with CHC rela

229 Poisson modeling was used to estimate the mortality rate ratio (MRR) for women compared with men a

230 a substantially lower mortality rate ratio (mortality rate ratio = 0.64, 95% confidence interval: 0.

231 The 30-day adjusted mortality rate ratio for isolated CABG surgery was 13.51

232 We calculated mortality rate ratios (MRR) to account for differences i

233 eference population, fibrosis stage-specific mortality rate ratios (MRRs) with 95% confidence interva

234 the future as long as prey availability and mortality rates remain within the ranges observed during

235 in patients with wild-type BRAF, in whom the mortality rate remained low and flat with increasing age

236 5%) and 0.51% (95% CI, 0.41%-0.61%) in daily mortality rate, respectively.

237 for a more accurate estimation of sea turtle mortality rates resulting from different fisheries and f

238 The high mortality rate results from a lack of methods for early

239 alent CH we detect associates with increased mortality rates, risk for hematological malignancy, smok

240 In-hospital risk-standardized mortality rate (RSMR) calculated using hierarchical mode

241 Publicly reported hospital risk-standardized mortality rates (RSMRs) for acute myocardial infarction

242 Mortality rates significantly increase after 12 hours of

243 es in age-adjusted all-cause and HIV-related mortality rates since 2010, coincident with the scale-up

244 Adjusted mortality rates slightly declined over the study period.

245 In fact, in each model, mortality rates tended to fall in the days after day 30,

246 ockers (n = 522) had a lower cancer-specific mortality rate than nonusers (adjusted HR, 0.79; 95% CI,

247 higher risk of sepsis and a 100-fold higher mortality rate than the general population with sepsis.

248 Unemployed men had higher mortality rates than men in any occupation and industry

249 hough patients with BAV and raphe had higher mortality rates than patients without, the presence of a

250 stula placement also had significantly lower mortality rates than the catheter group had over 58 mont

251 People with mental disorders have higher mortality rates than the general population and more det

252 or state insurance coverage only had higher mortality rates than those with additional commercial in

253 had significantly higher CNS viral loads and mortality rates than wild-type animals.

254 al hemorrhagic fevers, because of their high mortality rates, the lack of medical countermeasures, an

255 rognosis, limited clinical therapy, and high mortality rate together demonstrate that the development

256 andard BP lowering treatment groups in total mortality rates, unfavorable outcomes, hematoma expansio

257 For gastric cancer, the highest mortality rate was "agriculture" (by occupation) and "mi

258 The 90-day postoperative mortality rate was 0% in both groups.

259 e was 0.84, 0.87, and 0.89; and standardized mortality rate was 0.92, 1.05 and 1.10, respectively.

260 The all-cause 30-day in-hospital mortality rate was 10 in 10 000.

261 The neonatal mortality rate was 11.78 (95% CI 5.92-23.46) per 1000 li

262 The 30-day mortality rate was 15.3% with no procedure-related death

263 The annual mortality rate was 2.20% (95% confidence interval [CI],

264 The mortality rate was 20%.

265 The in-hospital mortality rate was 20.4%.

266 The cumulative 2-year mortality rate was 26.0% in the intervention group and 3

267 The crude 30-day all-cause mortality rate was 30.8% (97/315).

268 6.2) years of follow-up, the alcohol-related mortality rate was 4.8 per 10000 person-years (95% CI, 4

269 The neonatal mortality rate was 42 deaths per 1000 livebirths in inte

270 The mortality rate was also significantly higher in patients

271 A reduced 14-day mortality rate was observed in the molecular adsorbent r

272 ing of consultants revealed that the overall mortality rate was significantly higher for visitors (od

273 The 1-year all-cause mortality rate was significantly higher in the patients

274 The 1-year all-cause mortality rate was significantly higher in the ViR group

275 ates (<2500 g at inclusion) to reduce infant mortality rates, we observed a very beneficial effect in

276 Absolute risk differences in daily mortality rate were 1.42 (95% CI, 1.29-1.56) and 0.66 (9

277 Thirty-day all-cause and attributable mortality rates were 10% (2/21) and 5% (1/21), respectiv

278 The 28- and 90-day mortality rates were 10-12 % higher than the original Va

279 The overall 3-day, in-ICU, and in-hospital mortality rates were 14.1%, 37.3%, and 41.3%, respective

280 er TAVR, all-cause and cardiovascular 30-day mortality rates were 2.4% and 1.4%, respectively.

281 Overall mortality rates were 20.3% and 18.0%, respectively (p =

282 all in-ICU, in-hospital, 6-month, and 1-year mortality rates were 37%, 58%, 74%, and 88%, respectivel

283 In-hospital and 30-day mortality rates were 4.4% and 5.4%, respectively, in FRA

284 % (1/21), respectively; corresponding 90-day mortality rates were 48% (10/21) and 19% (4/21).

285 and 6.8 cases, respectively, and inhospital mortality rates were 5.9% and 4.8%, respectively.

286 Thirty-day and 90-day mortality rates were 6.3% and 15.5%.

287 a never-pregnant female donor vs male donor, mortality rates were 74 vs 62 per 1000 person-years (HR,

288 a never-pregnant female donor vs male donor, mortality rates were 78 vs 80 deaths per 1000 person-yea

289 Annual mortality rates were calculated by dividing the Kaplan-M

290 ng pediatric hospitals, annual risk-adjusted mortality rates were calculated for sites between 2000 a

291 In-hospital postoperative morbidity and mortality rates were comparable between groups.

292 The highest mortality rates were estimated in sub-Saharan Africa (2.

293 The lowest cardiovascular mortality rates were found in the counties surrounding S

294 ollow-up, (aborted) sudden cardiac death and mortality rates were found to be similarly low.

295 Overall ICU mortality rates were higher in visitor intensivists, alb

296 The highest mortality rates were in elementary construction (701 dea

297 n prenatal smoking and NEC-associated infant mortality rates with adjustment for potential confounder

298 We aimed to determine whether higher mortality rates with high milk consumption are modified

299 There was a high mortality rate within the first months after discharge.

300 and of age at entry and how much higher the mortality rates would have to be in nonparticipants than